Sign In
to Vote &
Create Storyboards.
 
Pfizer announced this week that the COVID-19 vaccine they’re developing showed a 90% efficacy rate during a preliminary clinical trial. It’s still early days, and there’s no concrete timeline on when the vaccine, if it is indeed effective, might be made available to the public. But with some tentative light now visible at the end […]
3
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard